528 related articles for article (PubMed ID: 28811708)
1. Involvement of CRF2 signaling in enterocyte differentiation.
Ducarouge B; Pelissier-Rota M; Powell R; Buisson A; Bonaz B; Jacquier-Sarlin M
World J Gastroenterol; 2017 Jul; 23(28):5127-5145. PubMed ID: 28811708
[TBL] [Abstract][Full Text] [Related]
2. A crosstalk between muscarinic and CRF2 receptors regulates cellular adhesion properties of human colon cancer cells.
Pelissier-Rota M; Chartier NT; Bonaz B; Jacquier-Sarlin MR
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1246-1259. PubMed ID: 28432022
[TBL] [Abstract][Full Text] [Related]
3. Potential Regulatory Effects of Corticotropin-Releasing Factor on Tight Junction-Related Intestinal Epithelial Permeability are Partially Mediated by CK8 Upregulation.
Yue H; Bin L; Chaoying C; Meng Z; Meng L; Xi W
Cell Physiol Biochem; 2017; 44(3):1161-1173. PubMed ID: 29179184
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
[TBL] [Abstract][Full Text] [Related]
5. Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.
Yuan PQ; Wu SV; Pothoulakis C; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G387-98. PubMed ID: 26744472
[TBL] [Abstract][Full Text] [Related]
6. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability.
D'Costa S; Ayyadurai S; Gibson AJ; Mackey E; Rajput M; Sommerville LJ; Wilson N; Li Y; Kubat E; Kumar A; Subramanian H; Bhargava A; Moeser AJ
J Allergy Clin Immunol; 2019 May; 143(5):1865-1877.e4. PubMed ID: 30439403
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.
Chatzaki E; Anton PA; Million M; Lambropoulou M; Constantinidis T; Kolios G; Taché Y; Grigoriadis DE
World J Gastroenterol; 2013 Mar; 19(9):1416-23. PubMed ID: 23539366
[TBL] [Abstract][Full Text] [Related]
8. Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.
Mahajan S; Liao M; Barkan P; Takahashi K; Bhargava A
Peptides; 2014 Apr; 54():58-66. PubMed ID: 24462512
[TBL] [Abstract][Full Text] [Related]
9. Activation of the epithelial-to-mesenchymal transition factor snail mediates acetaldehyde-induced intestinal epithelial barrier disruption.
Elamin E; Masclee A; Troost F; Dekker J; Jonkers D
Alcohol Clin Exp Res; 2014 Feb; 38(2):344-53. PubMed ID: 24033729
[TBL] [Abstract][Full Text] [Related]
10. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
11. Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor-mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human.
Zong Y; Zhu S; Zhang S; Zheng G; Wiley JW; Hong S
Neurogastroenterol Motil; 2019 Feb; 31(2):e13477. PubMed ID: 30284340
[TBL] [Abstract][Full Text] [Related]
12. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
13. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
[TBL] [Abstract][Full Text] [Related]
14. A Novel Pharmacological Approach to Enhance the Integrity and Accelerate Restitution of the Intestinal Epithelial Barrier.
Cao X; Sun L; Lechuga S; Naydenov NG; Feygin A; Ivanov AI
Inflamm Bowel Dis; 2020 Aug; 26(9):1340-1352. PubMed ID: 32266946
[TBL] [Abstract][Full Text] [Related]
15. The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.
Lu B; Diz-Chaves Y; Markovic D; Contarino A; Penicaud L; Fanelli F; Clark S; Lehnert H; Cota D; Grammatopoulos DK; Tabarin A
Int J Obes (Lond); 2015 Mar; 39(3):408-17. PubMed ID: 25189177
[TBL] [Abstract][Full Text] [Related]
16. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
[TBL] [Abstract][Full Text] [Related]
17. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
Tasma Z; Wills P; Hay DL; Walker CS
Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.
Wu SV; Yuan PQ; Wang L; Peng YL; Chen CY; Taché Y
Endocrinology; 2007 Apr; 148(4):1675-87. PubMed ID: 17218420
[TBL] [Abstract][Full Text] [Related]
19. Numb modulates the paracellular permeability of intestinal epithelial cells through regulating apical junctional complex assembly and myosin light chain phosphorylation.
Yang Y; Chen L; Tian Y; Ye J; Liu Y; Song L; Pan Q; He Y; Chen W; Peng Z; Wang R
Exp Cell Res; 2013 Dec; 319(20):3214-25. PubMed ID: 23872314
[TBL] [Abstract][Full Text] [Related]
20. CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats.
Million M; Wang L; Wang Y; Adelson DW; Yuan PQ; Maillot C; Coutinho SV; Mcroberts JA; Bayati A; Mattsson H; Wu V; Wei JY; Rivier J; Vale W; Mayer EA; Taché Y
Gut; 2006 Feb; 55(2):172-81. PubMed ID: 15985561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
